The American College of Obstetricians and Gynecologists/Bayer HealthCare Pharmaceuticals Research Award in Contraception
Kristina Tocce, MD
University of Colorado Health Sciences Center
"Delay of Rapid Repeat Teen Pregnancy: Immediate Post-partum Subdermal Contraception"
Tessa Madden, MD, MPH
Johns Hopkins Bayview Medical Center
"The Estradiol Patch for the Management of Intermenstrual Bleeding in Levonorgesterol Intrauterine Device Users"
Nicole W. Karjane, MD
Virginia Commonwealth University Medical Center
"Quick Start Initiation of the Contraceptive Vaginal Ring in Adolescents: A Randomized Controlled Trial"
Zev Williams, MD
Brigham and Women's Hospital
"Designing an Immunocontraceptive"
Jenell S. Coleman, MD
University of California, San Francisco
"Levonorgestrel-releasing Intrauterine Device in Women Infected with HIV-1 and its Effect on Genital Viral Shedding"
Kathryn H. Ostrom, MD
University of New Mexico Health Science Center
"Comparison of Progestin-only Oral Contraceptives to Combined Oral Contraceptive for Postpartum Breastfeeding Women"
Carrie Cwiak, MD/Alison B. Edelman, MD
Emory University School of Medicine/Oregon Health Sciences University
"A Multimedia Interactive Presentation for Teaching Contraception to Medical Students"
Kenneth D. Clark, MD
Robert C. Byrd Health Sciences Center of West Virginia University-Charleston Division
"Depot Medroxyprogesterone Acetate as a Contraceptive and Bone Loss in Young Women: Is Concomitant Low Dose Transdermal Estrogen Beneficial"
A. Wendy Askew, MD
Milford Hall Medical Center/Brooke Army Medical Center
"A Randomized, Double-blinded, Controlled Clinical Trial in Adolescent Patients to Evaluate the Effects on Cycle Control of the Three 20mcg Containing OCs that are Currently Available in the United States"
Melissa Gilliam, MD
University of Illinois at Chicago
"Increasing Oral Contraceptive Use and Compliance Among Young Hispanic Women"
Daniel M. Breitkopf, MD
University of Texas Medical Branch at Galveston
"Investigation of the Clinical Efficacy of Second- versus Third-generation Oral Contraceptives in the Treatment of Hyperandrogenic Syndromes"